Advancing Drug Discovery for Neurodegenerative Disease Using iPSC Technology
Time: 11:30 am
day: Conference Day One
Details:
- Development of multiple neuronal & glial cell types from healthy and disease patient iPSC lines
- Validation of morphological and functional capabilities from the iPSC-derived neurons, astrocytes, and microglia across mono-, co-, and triculture models
- Current capabilities and potential future applications in advancing personalized medicine for Alzheimer’s disease & other neurodegenerative diseases
- Demonstrating how these models improve target discovery, biomarker validation, and preclinical predictability in drug development
